News in Pathophysiology, Definition and Classification of Hepatorenal Syndrome: a step beyond the International Club of Ascites (ICA) Consensus document.

[1]  W. Jiménez,et al.  Neutrophil Gelatinase‐Associated Lipocalin for Assessment of Acute Kidney Injury in Cirrhosis: A Prospective Study , 2019, Hepatology.

[2]  R. Moreau,et al.  Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis. , 2019, Gastroenterology.

[3]  A. de Gottardi,et al.  Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis , 2019, Front. Immunol..

[4]  S. Sarin,et al.  Terlipressin Is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute on Chronic Liver Failure , 2019, Hepatology.

[5]  F. Nevens,et al.  Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome , 2018, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[6]  M. Verma,et al.  Noradrenaline for reverting hepatorenal syndrome: a prospective, observational, single-center study , 2018, Clinical and experimental gastroenterology.

[7]  J. Trebicka,et al.  EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. , 2018, Journal of hepatology.

[8]  L. Kang,et al.  Fractional excretion of urea: A simple tool for the differential diagnosis of acute kidney injury in cirrhosis , 2018, Hepatology.

[9]  R. Amathieu,et al.  Significance of oliguria in critically ill patients with chronic liver disease , 2017, Hepatology.

[10]  Allison R. Schulman,et al.  Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome. , 2017, The Cochrane database of systematic reviews.

[11]  R. Bellomo,et al.  EXPERT CONSENSUS DOCUMENT: Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup , 2017 .

[12]  K. Reddy,et al.  Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT‐0401 and REVERSE randomised clinical studies , 2017, Alimentary pharmacology & therapeutics.

[13]  M. Murad,et al.  Comparative efficacy of pharmacological strategies for management of type 1 hepatorenal syndrome: a systematic review and network meta-analysis. , 2017, The lancet. Gastroenterology & hepatology.

[14]  F. Durand,et al.  Kidney biomarkers in cirrhosis. , 2016, Journal of hepatology.

[15]  Richard Moreau,et al.  Systemic inflammation in decompensated cirrhosis: Characterization and role in acute‐on‐chronic liver failure , 2016, Hepatology.

[16]  D. Ganger,et al.  Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1. , 2016, Gastroenterology.

[17]  L. Henry,et al.  Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in the United States and the Rest of the World. , 2016, Clinics in liver disease.

[18]  E. Bugianesi,et al.  Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults. , 2016, Clinics in liver disease.

[19]  R. Hirose,et al.  Simultaneous Liver–Kidney Allocation Policy: A Proposal to Optimize Appropriate Utilization of Scarce Resources , 2016, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[20]  A. Frigo,et al.  Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: A randomized controlled study , 2016, Hepatology.

[21]  S. Sarin,et al.  SIRS at Admission Is a Predictor of AKI Development and Mortality in Hospitalized Patients with Severe Alcoholic Hepatitis , 2016, Digestive Diseases and Sciences.

[22]  R. Moreau,et al.  Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis. , 2015, Journal of hepatology.

[23]  M. Navasa,et al.  Treatment of type 2 hepatorenal syndrome in patients awaiting transplantation: Effects on kidney function and transplantation outcomes , 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[24]  A. Frigo,et al.  New ICA criteria for the diagnosis of acute kidney injury in cirrhotic patients: can we use an imputed value of serum creatinine? , 2015, Liver international : official journal of the International Association for the Study of the Liver.

[25]  Ezio Fornasiere,et al.  Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial , 2015, Hepatology.

[26]  W. Jiménez,et al.  Analysis of a Urinary Biomarker Panel for Clinical Outcomes Assessment in Cirrhosis , 2015, PloS one.

[27]  F. Wong,et al.  Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation , 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[28]  William M. Lee,et al.  Risk factors and outcomes of acute kidney injury in patients with acute liver failure. , 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[29]  W. Kim,et al.  Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites , 2015, Gut.

[30]  M. Naldi,et al.  Posttranscriptional changes of serum albumin: Clinical and prognostic significance in hospitalized patients with cirrhosis , 2014, Hepatology.

[31]  M. Perazella,et al.  Kidney biomarkers and differential diagnosis of patients with cirrhosis and acute kidney injury , 2014, Hepatology.

[32]  K. Reddy,et al.  Survival in infection‐related acute‐on‐chronic liver failure is defined by extrahepatic organ failures , 2014, Hepatology.

[33]  M. Poca,et al.  Terlipressin and albumin for type-1 hepatorenal syndrome associated with sepsis. , 2014, Journal of hepatology.

[34]  R. Moreau,et al.  Glomerular filtration rate equations for liver‐kidney transplantation in patients with cirrhosis: Validation of current recommendations , 2014, Hepatology.

[35]  J. Kellum,et al.  A Unified Theory of Sepsis-Induced Acute Kidney Injury: Inflammation, Microcirculatory Dysfunction, Bioenergetics, and the Tubular Cell Adaptation to Injury , 2014, Shock.

[36]  H. Denk,et al.  Bile acids trigger cholemic nephropathy in common bile‐duct–ligated mice , 2013, Hepatology.

[37]  P. Kamath,et al.  Original ResearchFull Report: Clinical—LiverNew Consensus Definition of Acute Kidney Injury Accurately Predicts 30-Day Mortality in Patients With Cirrhosis and Infection , 2013 .

[38]  A. Frigo,et al.  Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites. , 2013, Journal of hepatology.

[39]  E. Poch,et al.  A modified acute kidney injury classification for diagnosis and risk stratification of impairment of kidney function in cirrhosis. , 2013, Journal of hepatology.

[40]  F. Salem,et al.  Bile cast nephropathy is a common pathologic finding for kidney injury associated with severe liver dysfunction. , 2013, Kidney international.

[41]  R. Moreau,et al.  Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. , 2013, Gastroenterology.

[42]  V. Paradis,et al.  Increased renal expression and urinary excretion of TLR4 in acute kidney injury associated with cirrhosis , 2013, Liver international : official journal of the International Association for the Study of the Liver.

[43]  A. Sanyal,et al.  Association of AKI With mortality and complications in hospitalized patients with cirrhosis , 2013, Hepatology.

[44]  P. Angeli,et al.  Positive cardiac inotropic effect of albumin infusion in rodents with cirrhosis and ascites: molecular mechanisms , 2013, Hepatology.

[45]  P. Angeli,et al.  Hepatorenal syndrome, MELD score and liver transplantation: an evolving issue with relevant implications for clinical practice. , 2012, Journal of hepatology.

[46]  Johnny C. Hong,et al.  Simultaneous Liver–Kidney Transplantation Summit: Current State and Future Directions , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[47]  A. Khwaja.  KDIGO Clinical Practice Guidelines for Acute Kidney Injury , 2012, Nephron Clinical Practice.

[48]  W. Jiménez,et al.  Urinary neutrophil gelatinase-associated lipocalin as biomarker in the differential diagnosis of impairment of kidney function in cirrhosis. , 2012, Journal of hepatology.

[49]  T. Nickolas,et al.  Urinary Neutrophil Gelatinase-Associated Lipocalin Predicts Mortality and Identifies Acute Kidney Injury in Cirrhosis , 2012, Digestive Diseases and Sciences.

[50]  W. Ye,et al.  Impact of the etiology of acute kidney injury on outcomes following liver transplantation: acute tubular necrosis versus hepatorenal syndrome , 2012, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[51]  R. Jalan,et al.  Prevention of acute kidney injury in a rodent model of cirrhosis following selective gut decontamination is associated with reduced renal TLR4 expression. , 2012, Journal of hepatology.

[52]  A. Sanyal,et al.  Impact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1 * , 2011, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[53]  Arun J. Sanyal,et al.  Predictors of response to terlipressin plus albumin in hepatorenal syndrome (HRS) type 1: relationship of serum creatinine to hemodynamics. , 2011, Journal of hepatology.

[54]  C. Edelstein,et al.  Clinical applications of biomarkers for acute kidney injury. , 2011, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[55]  R. Bellomo,et al.  Working Party proposal for a revised classification system of renal dysfunction in patients with cirrhosis , 2011, Gut.

[56]  R. Moreau,et al.  Inaccuracies of creatinine and creatinine‐based equations in candidates for liver transplantation with low creatinine: Impact on the model for end‐stage liver disease score , 2010, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[57]  V. Paradis,et al.  The spectrum of renal lesions in patients with cirrhosis: a clinicopathological study , 2010, Liver international : official journal of the International Association for the Study of the Liver.

[58]  P. Karakiewicz,et al.  Effects of Phlebotomy and Phenylephrine Infusion on Portal Venous Pressure and Systemic Hemodynamics During Liver Transplantation , 2010, Transplantation.

[59]  E. Christensen,et al.  Systematic review of randomized trials on vasoconstrictor drugs for hepatorenal syndrome , 2010, Hepatology.

[60]  C. Sakamoto,et al.  Effects of terlipressin on systemic, hepatic and renal hemodynamics in patients with cirrhosis , 2009, Journal of gastroenterology and hepatology.

[61]  A. Krag,et al.  Low cardiac output predicts development of hepatorenal syndrome and survival in patients with cirrhosis and ascites , 2009, Gut.

[62]  P. Angeli,et al.  Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial , 2009, Gut.

[63]  Guy Roey,et al.  The hepatorenal syndrome , 2009, Pediatric Nephrology.

[64]  T. Gonwa,et al.  Kidney Allocation to Liver Transplant Candidates with Renal Failure of Undetermined Etiology: Role of Percutaneous Renal Biopsy , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[65]  P. Hayes,et al.  The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure , 2008, Gut.

[66]  D. Gerber,et al.  Proceedings of Consensus Conference on Simultaneous Liver Kidney Transplantation (SLK) , 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[67]  S. Sarin,et al.  An Open Label, Pilot, Randomized Controlled Trial of Noradrenaline Versus Terlipressin in the Treatment of Type 1 Hepatorenal Syndrome and Predictors of Response , 2008, The American Journal of Gastroenterology.

[68]  V. Arroyo,et al.  Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study. , 2008, Gastroenterology.

[69]  M. Rizzetto,et al.  Noradrenalin vs terlipressin in patients with hepatorenal syndrome: a prospective, randomized, unblinded, pilot study. , 2007, Journal of hepatology.

[70]  K. Reddy,et al.  Simultaneous Liver–Kidney Transplantation: Evaluation to Decision Making , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[71]  G. Klintmalm,et al.  Hepatorenal syndrome: A proposal for kidney after liver transplantation (KALT) , 2007, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[72]  A. Gerbes,et al.  Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis , 2007, Postgraduate Medical Journal.

[73]  E. Esrailian,et al.  Octreotide/Midodrine Therapy Significantly Improves Renal Function and 30-Day Survival in Patients with Type 1 Hepatorenal Syndrome , 2007, Digestive Diseases and Sciences.

[74]  P. Angeli,et al.  Renal failure and bacterial infections in patients with cirrhosis: Epidemiology and clinical features , 2007, Hepatology.

[75]  M. Navasa,et al.  Renal failure in patients with cirrhosis and sepsis unrelated to spontaneous bacterial peritonitis: value of MELD score. , 2005, Gastroenterology.

[76]  J. Henriksen,et al.  Plasma volume expansion by albumin in cirrhosis. Relation to blood volume distribution, arterial compliance and severity of disease. , 2003, Journal of hepatology.

[77]  R. Moreau,et al.  Acute renal failure in patients with cirrhosis: Perspectives in the age of MELD , 2003, Hepatology.

[78]  L. Chauvelot‐Moachon,et al.  Terlipressin inhibits in vivo aortic iNOS expression induced by lipopolysaccharide in rats with biliary cirrhosis , 2002, Hepatology.

[79]  R. Bataller,et al.  Terlipressin therapy with and without albumin for patients with hepatorenal syndrome: Results of a prospective, nonrandomized study , 2002, Hepatology.

[80]  R. Moreau,et al.  Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study. , 2002, Gastroenterology.

[81]  T. Reynolds,et al.  Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial. , 2000, Gastroenterology.

[82]  R. Bataller,et al.  Terlipressin plus albumin infusion: an effective and safe therapy of hepatorenal syndrome. , 2000, Journal of hepatology.

[83]  M. Navasa,et al.  Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. , 1999, The New England journal of medicine.

[84]  P. Angeli,et al.  Reversal of type 1 hepatorenal syndrome with the administration of midodrine and octreotide , 1999, Hepatology.

[85]  W. Jiménez,et al.  Tumor necrosis factor and interleukin‐6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality , 1998, Hepatology.

[86]  J. Rodés,et al.  Time profile of the haemodynamic effects of terlipressin in portal hypertension. , 1997, Journal of hepatology.

[87]  W. Jiménez,et al.  Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. , 1996, Gastroenterology.

[88]  J. Schölmerich,et al.  Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis , 1996, Hepatology.

[89]  J. Llovet,et al.  Renal impairment after spontaneous bacterial peritonitis in cirrhosis: Incidence, clinical course, predictive factors and prognosis , 1994, Hepatology.

[90]  Vicente Arroyo,et al.  Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis , 1988, Hepatology.

[91]  J. Diamond,et al.  Nonoliguric acute renal failure associated with a low fractional excretion of sodium. , 1982, Annals of internal medicine.

[92]  M. Geuking,et al.  Pathological bacterial translocation in liver cirrhosis. , 2014, Journal of hepatology.

[93]  P. Angeli,et al.  Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis. , 2008, Journal of hepatology.

[94]  W. Jiménez,et al.  LIVER FAILURE AND LIVER DISEASE , 2005 .

[95]  W. Jiménez,et al.  LIVER FAILURE AND LIVER DISEASE , 2005 .

[96]  Vicente Arroyo,et al.  LIVER FAILURE AND LIVER DISEASE , 2005 .